Metabolic CRO Focus ProSciento specializes in metabolic diseases and has conducted over 425 metabolic clinical trials, indicating deep domain expertise and a proven track record that can reassure potential clients seeking specialized metabolic trial support.

Growth & Leadership Revenue range of 25M to 50M and a recent COO appointment suggest scaling operations and leadership execution, signaling readiness to take on larger or more complex multinational trials.

Strategic Partnerships Ongoing partnerships with the Breakthrough Therapy for Type 1 Diabetes program and ADA sponsorship demonstrate strong relationships with patient advocacy and diabetes communities, which can be leveraged for patient recruitment and trial visibility.

Clinical Innovation Recognition with the 2023 Innovation Award and hosting industry roundtables indicate a commitment to innovation and thought leadership, opening opportunities for collaboration on cutting-edge trial designs and protocols.

Talent & Engagement New hires in leadership (COO) and People roles show investment in organizational capability and talent management, which can translate to better program governance, site management, and patient engagement across studies.